Evolving Landscape of Cell & Gene Therapy CDMOs
The global cell and gene therapy CDMO market is undergoing rapid transformation, driven by the increasing complexity of advanced therapeutics and the growing reliance on outsourcing. A biopharmaceutical CDMO today is no longer limited to traditional manufacturing; it has evolved into a strategic partner offering end-to-end CDMO services, from...
The global hemophilia treatment market is witnessing steady growth driven by advancements in therapeutic approaches, increasing awareness about rare bleeding disorders, and improved healthcare infrastructure across emerging and developed economies. Hemophilia, a genetic disorder that impairs the body’s ability to make blood clots, requires long-term management through factor replacement...